Loading…
MAZE
Maze Therapeutics, Inc.
NASDAQ· Healthcare· Biotechnology· CUSIP 578784100
$27.53+0.18%Price as of Oct 17, 12:03 UTC · updated once a day, after the close
At a glance
Maze Therapeutics, Inc. (MAZE) is listed on NASDAQ and classified in Biotechnology, part of the Healthcare sector. It is headquartered in South San Francisco, United States and has 141 employees. The company is worth $1.53B. Revenue was $167.5M in fiscal 2024. Net income was $52.23M. The share price is 48.7% below its 52-week high of $53.65. 3 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Ken Griffin (Citadel Advisors), at $25.44M. In that quarter, 2 of them opened or added to the position. Over the last 30 days, company insiders sold $1.57M of its stock on the open market and bought none. All of those sales were scheduled in advance under 10b5-1 plans.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $1.53B
- P/E
- —
- Forward P/E
- —
- P/B
- 3.4x
- Dividend yield
- 0.00%
- Payout
- —
- EPS
- -$2.48
- ROE
- -37.35%
- Profit margin
- 0.00%
- Revenue growth
- —
- Beta
- —
- 52-week high
- $53.65
- 52-week low
- $21.95
History
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▲ +72.6% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| INVAInnoviva, Inc. | $21.06 | 4.9x | 1.2x | 0.00% | 36.68% | $1.52B |
| CERTCertara, Inc. | $10.09 | — | 1.6x | 0.00% | -2.21% | $1.54B |
| AGLagilon health, inc. | $90.29 | — | 6.7x | 0.00% | -78.94% | $1.52B |
| GENBGenerate Biomedicines, Inc. | $12.09 |
About the company
- 141
- South San Francisco, United States